MCAM expression is associated with poor prognosis in non-small cell lung cancer.

@article{Zhang2014MCAMEI,
  title={MCAM expression is associated with poor prognosis in non-small cell lung cancer.},
  author={Xiaoying Zhang and Zhengyan Wang and Yu Kang and Xiao Li and Xiaoyan Ma and L Ma},
  journal={Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico},
  year={2014},
  volume={16 2},
  pages={178-83}
}
BACKGROUND MCAM has been recently identified as a biomarker for epithelial-mesenchymal transition (EMT) and is potentially involved in metastasis of cancer. The current study aimed at investigating the expression of MCAM in non-small-cell lung cancer (NSCLC) and its clinico-pathological significance. METHODS A follow-up analysis was performed on 118 patients with NSCLC resected by lobectomy or pneumectomy with systematic lymph node dissection. All patients were followed for 6-60 months… CONTINUE READING
10 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…